Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus.

Related research

• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med · 2016 · 5696 citations
• A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med · 2015 · 2023 citations
• Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet · 2016 · 1746 citations
• Liraglutide and Renal Outcomes in Type 2 Diabetes. N Engl J Med · 2017 · 954 citations
• Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial. JAMA · 2015 · 866 citations
• The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Invest · 2014 · 798 citations
• Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA · 2022 · 755 citations
• The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne) · 2019 · 703 citations